spacer
home > pmps > current issue
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Autumn 2019

   
Text
PDF
bullet
Feature topics
Modern Manufacturing

Five Ways AR is Revolutionising the Manufacturing Industry

A few years ago, AR was a near impossibility, but now it is a thing of reality, and Patrick Liddy at UtilityAR illustrates the benefits this is having on the workforce and in the manufacturing industry.
 
view
download pdf
Cleanrooms and Sterilisation

The Hygiene Regime

To reduce the risks of contamination, cleanroom areas and staff have to be kept as hygienic as possible, and Sue Springett at Teknomek illustrates how to maintain this sterile environment.
 
view
download pdf
Q&A: Academia-Industry Collaborations

Advancing Pharmaceutical R&D

David Harris, Dr Hugh Smyth, Dr Joanne Peart, and Dr David Lewis at Chiesi debate and discuss the dynamic relationship between universities and the pharmaceutical industry in a Q&A with PMPS.
 
view
download pdf
Spotlight

Taking Our Breath Away

H&T Presspart discuss their new respiratory device, eMDI™, which aims to help patients with inhalation adherence so they can lead healthier lives.
 
view
download pdf
Adapting to EU Regulations

Regulation, Regulation, Regulation

Elizma Parry at Maetrics examines legislation surrounding medical device regulations adopted in 2017 and the upheaval this may cause for those in the industry developing companion diagnostics or combination products.
 
view
download pdf
Track and Trace Technologies

A Vision of Full Integration

Federico Piutti at Bormioli Pharma supports the trend towards more digital technologies and serialisation in the supply chain, as he believes these technologies will allow for a safer supply of drugs to patients.
 
view
download pdf
Smart Manufacturing

The Challenges in Starting 4.0 Projects

Denis Decubber at SalamanderU evaluates the current phenomenon of smart industry technology in manufacturing processes, from pharma 4.0 to smart manufacturing and fill and finish.
 
view
download pdf
Industry Insight

Randice Altschul, PMPS’s Industry Advisor, comments on articles within this edition, with a primary focus on cold chain processes, innovations in labelling, and the Asian pharma market.
 
view
download pdf
bullet
Innovative Packaging and Labelling
Label Translation Accuracy

Translation: An Art, Not a Science

Mike Hunter at Better Languages examines the complexities of label translation on medicinal products and the ramifications that may occur if mistakes are made.
 
view
download pdf
IoT Applications

A Revolution for Supply Chains

Nurdan Citamak at Faubel Pharma Services writes on the complex and demand-driven supply chain, and how innovative smart labels coupled with IoT technologies can help save time as well as money.
 
view
download pdf
Evolutions in Pharma Packaging

Preparing for Change

The pharmaceutical packaging industry is always aiming to advance, and Dexter Tjoa at Tjoapack analyses the role of technology that helps facilitate these trends.
 
view
download pdf
Label Translation Challenges

Lost in Translation

It is important to know the labelling requirements of your destination country when exporting products internationally, and Alison Senyi at Nexreg Compliance discusses the difficulties of this for companies that seek to find the perfect translation.
 
view
download pdf
bullet
The Asian Pharma Market
Regional Focus: Asia

Exploring Asia

The biggest continent also wants to be the biggest pharmaceutical market in the world. Zdeněk Pečený writes on Asia’s pro-innovation and pro-biotechnology trends that may allow this vision to become a reality.
 
view
download pdf
CMOs in Asia

When is a CMO not a CMO?

Hugh Williams at EFESO Consulting examines the role of CMOs in Asia, discerning that they need to change fundamentally if they wish to survive and thrive in the modern supply chain industry.
 
view
download pdf
bullet
Cold Chain Challenges
Spotlight

Ensuring a Seamless Cool Chain

PMPS sits down with Guillaume Halleux at Qatar Airways Cargo, discussing the cold chain industry in which it operates and the methods it uses to ensure the successful delivery of its temperature-sensitive products.
 
view
download pdf
Pharma Cold Chain

The Impact of Emerging Trends

Dr Ruediger Lomb at World Courier examines the pharmaceutical cold chain, noting the trend towards more high-precision, low-volume therapies, but also the negative trend of growing prices.
 
view
download pdf
Airport Ground Handling

Hurdles in Cold Chain

No part of the cold chain process from manufacturer to end user is unimportant, and Paul Cheng at Hactl examines perhaps one of the most important aspects: ground handling at airports.
 
view
download pdf
Transforming Biopharma Cold Chains

Reliable Temperature Control

Sujan Thanjavuru at Clinical Data and SafeRxp theorises about how the cold chain can better cope with temperature excursions, which cost the industry $16 billion in economic losses every year.
 
view
download pdf
Spotlight

The ROI of Real-Time Supply Chain Visibility

Discover Controlant’s new real-time supply monitoring solutions, helping aid the entire cold chain from manufacturer through to last-mile and end user.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

• Collaboration to accelerate development and manufacturing of Bispecific Antibody • Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement